News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
111,551 Results
Type
Article (4304)
Company Profile (20)
Press Release (107227)
Multimedia
Podcasts (1)
Webinars (2)
Section
Business (32185)
Career Advice (109)
Deals (5296)
Drug Delivery (5)
Drug Development (5528)
Employer Resources (11)
FDA (3226)
Job Trends (2087)
News (47351)
Policy (3904)
Tag
Academia (367)
Accelerated approval (2)
Allergies (10)
Alliances (11247)
ALS (14)
Alzheimer's disease (381)
Antibody-drug conjugate (ADC) (13)
Approvals (3290)
Artificial intelligence (163)
Autoimmune disease (11)
Automation (11)
Bankruptcy (45)
Best Places to Work (1726)
BIOSECURE Act (1)
Biosimilars (11)
Biotechnology (11)
Bladder cancer (24)
Brain cancer (7)
Breast cancer (144)
Cancer (884)
Cardiovascular disease (53)
Career advice (100)
Career pathing (2)
CAR-T (16)
CDC (1)
Celiac Disease (1)
Cell therapy (41)
Cervical cancer (10)
Clinical research (4516)
Collaboration (356)
Compensation (26)
Complete response letters (3)
COVID-19 (486)
CRISPR (6)
C-suite (106)
Cystic fibrosis (14)
Data (664)
Decentralized trials (1)
Depression (14)
Diabetes (32)
Diagnostics (6123)
Digital health (19)
Diversity (1)
Diversity, equity & inclusion (3)
Drug discovery (27)
Drug pricing (4)
Drug shortages (2)
Duchenne muscular dystrophy (6)
Earnings (10999)
Editorial (1)
Employer branding (2)
Employer resources (11)
Events (14181)
Executive appointments (151)
FDA (3660)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (1)
Funding (231)
Gene editing (8)
Generative AI (10)
Gene therapy (25)
GLP-1 (53)
Government (630)
Guidances (63)
Healthcare (2938)
HIV (9)
IgA nephropathy (3)
Immunology and inflammation (7)
Immuno-oncology (4)
Indications (8)
Infectious disease (527)
Inflammatory bowel disease (14)
Influenza (21)
Intellectual property (26)
Interviews (12)
IPO (1832)
IRA (2)
Job creations (401)
Job search strategy (94)
JPM (2)
Kidney cancer (6)
Labor market (3)
Layoffs (24)
Leadership (1)
Legal (542)
Liver cancer (14)
Longevity (2)
Lung cancer (106)
Lymphoma (59)
Machine learning (7)
Management (3)
Manufacturing (99)
MASH (18)
Medical device (2534)
Medtech (2546)
Mergers & acquisitions (3642)
Metabolic disorders (75)
Multiple sclerosis (41)
NASH (3)
Neurodegenerative disease (48)
Neuropsychiatric disorders (3)
Neuroscience (510)
NextGen: Class of 2026 (733)
Non-profit (554)
Now hiring (3)
Obesity (22)
Opinion (17)
Ovarian cancer (30)
Pain (10)
Pancreatic cancer (33)
Parkinson's disease (28)
Partnered (3)
Patents (49)
Patient recruitment (39)
Peanut (4)
People (9271)
Pharmaceutical (1)
Pharmacy benefit managers (2)
Phase 1 (1333)
Phase 2 (1881)
Phase 3 (1739)
Pipeline (658)
Policy (4)
Postmarket research (214)
Preclinical (609)
Press Release (11)
Prostate cancer (76)
Psychedelics (1)
Radiopharmaceuticals (131)
Rare diseases (59)
Real estate (870)
Recruiting (5)
Regulatory (3282)
Reports (10)
Research institute (442)
Resumes & cover letters (15)
Rett syndrome (4)
RSV (2)
Schizophrenia (3)
Series A (30)
Series B (23)
Service/supplier (1)
Sickle cell disease (3)
Spinal muscular atrophy (10)
Sponsored (7)
Startups (628)
Stomach cancer (2)
Supply chain (8)
The Weekly (1)
Vaccines (52)
Venture capital (12)
Weight loss (9)
Women's health (23)
Date
Last 7 days (87)
Last 30 days (291)
Last 365 days (3872)
2026 (371)
2025 (4089)
2024 (5156)
2023 (6204)
2022 (10266)
2021 (9672)
2020 (9012)
2019 (6217)
2018 (4882)
2017 (5415)
2016 (5418)
2015 (6154)
2014 (4643)
2013 (4133)
2012 (4448)
2011 (4642)
2010 (4094)
Location
Africa (134)
Alabama (7)
Alaska (1)
Arizona (75)
Arkansas (2)
Asia (5492)
Australia (1308)
California (1352)
Canada (393)
China (62)
Colorado (110)
Connecticut (80)
Delaware (12)
Europe (15886)
Florida (206)
Georgia (65)
Idaho (4)
Illinois (171)
India (14)
Indiana (65)
Iowa (7)
Japan (49)
Kansas (14)
Kentucky (9)
Louisiana (5)
Maine (22)
Maryland (159)
Massachusetts (713)
Michigan (96)
Minnesota (103)
Mississippi (1)
Missouri (44)
Montana (6)
Nebraska (8)
Nevada (5)
New Hampshire (22)
New Jersey (271)
New Mexico (17)
New York (461)
North Carolina (250)
North Dakota (7)
Northern California (656)
Ohio (49)
Oklahoma (5)
Oregon (10)
Pennsylvania (130)
Rhode Island (7)
South America (156)
South Carolina (9)
Southern California (525)
Tennessee (59)
Texas (383)
United States (5293)
Utah (167)
Virginia (71)
Washington D.C. (9)
Washington State (131)
West Virginia (1)
Wisconsin (64)
Wyoming (2)
111,551 Results for "vela diagnostics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MoonLake Immunotherapeutics reports on week 16 results of the VELA Phase 3 hidradenitis suppurativa program with the Nanobody® sonelokimab
September 28, 2025
·
27 min read
Pharm Country
Vela Diagnostics Collaborates with SRL Inc. for Product Distribution in Japan
Vela Diagnostics announced a research collaboration with SRL Inc, a premier Japanese healthcare service company.
October 2, 2023
·
2 min read
Press Releases
BioMark Diagnostics Announces Publication of Peer-Reviewed Validation of Machine Learning Models for Lung Cancer Detection in Frontiers in Oncology
Advancing Superior Accuracy in Early Lung Cancer Detection Using Selective Metabolic Pathways and Data Enrichment for Enhanced Diagnostic Capabilities
January 15, 2026
·
4 min read
MoonLake Immunotherapeutics starts Phase 3 VELA program of the Nanobody® sonelokimab in patients with moderate-to-severe hidradenitis suppurativa
MoonLake Immunotherapeutics today announced that the first patients have been screened at a U.S. trial site in its global Phase 3 clinical program, VELA, evaluating sonelokimab, an investigational Nanobody® designed to treat inflammatory disease, in patients with moderate-to-severe hidradenitis suppurativa (HS).
May 16, 2024
·
13 min read
Press Releases
Early Detection Of Breast Cancer Seen As A Benefit With Seated Option in the VELA Mammography Chair, Enable Me Finds in Technologist Survey
February 12, 2025
·
3 min read
Vela Diagnostics Develops PCR-based Test for Detecting Monkeypox Virus
Vela Diagnostics announced that it has developed a PCR test kit to detect the monkeypox virus, for research use only.
July 26, 2022
·
2 min read
Drug Development
Vela Diagnostics Supports COVID-19 Surveillance Efforts in Kenya
Vela Diagnostics has announced its appointment by the National Public Health Laboratory of Kenya as their supplier for SARS-CoV-2 genotyping tests, with funding from The Global Fund.
August 3, 2022
·
3 min read
Press Releases
MASHNET Announces Founding of MASLD Diagnostic Coalition
February 4, 2026
·
4 min read
Press Releases
Cleveland Diagnostics Names Jack Kenny as Chairman of the Board
February 5, 2026
·
2 min read
Pharm Country
Vela Diagnostics Launches Multiplex PCR-Based Test for Detecting UTI Pathogens and Antimicrobial Resistance Genes
Vela Diagnostics announced today the launch of its new PathoKey® MP UTI ID and AMR PCR Test for research use only (RUO*).
May 17, 2022
·
3 min read
1 of 11,156
Next
